Literature DB >> 12570105

Single arterial occlusion to locate resistance in patients with pulmonary hypertension.

P Fesler1, A Pagnamenta, J L Vachiéry, S Brimioulle, S Abdel Kafi, A Boonstra, M Delcroix, R N Channick, L J Rubin, R Naeije.   

Abstract

The purpose of this study was to determine the site of increased resistance using the arterial occlusion technique in patients with severe pulmonary hypertension. Pulmonary vascular resistance was partitioned in arterial and venous components based on double exponential fitting analysis of the pulmonary artery pressure decay curve: after balloon occlusion in 36 patients with pulmonary arterial hypertension (PAH); at baseline and during the inhalation of 20 parts per million of nitric oxide (NO); in four patients with chronic thromboembolic pulmonary hypertension; and in two patients with pulmonary veno-occlusive disease. In the patients with PAH, at baseline, mean pulmonary artery pressure was 56+/-2 mmHg (mean+/-SE), with an arterial component of resistance of 63+/-1%. Inhaled NO did not change the partition of resistance. The arterial component of resistance amounted on average to 42% and 77% in the patients with veno-occlusive disease and the patients with thromboembolic pulmonary hypertension, respectively. However, the partitioning of resistance did not discriminate between these three diagnostic categories. The occlusion technique may help to locate the predominant site of increased resistance in patients with severe pulmonary hypertension, but does not allow for a satisfactory differential diagnosis on an individual basis.

Entities:  

Mesh:

Year:  2003        PMID: 12570105     DOI: 10.1183/09031936.03.00054202

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  11 in total

Review 1.  Physiology of the pulmonary circulation and the right heart.

Authors:  Robert Naeije
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

2.  Hemodynamic assessment of pulmonary hypertension.

Authors:  Juan C Grignola
Journal:  World J Cardiol       Date:  2011-01-26

3.  Vascular stiffening in pulmonary hypertension: cause or consequence? (2013 Grover Conference series).

Authors:  Wei Tan; Krishna Madhavan; Kendall S Hunter; Daewon Park; Kurt R Stenmark
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

Review 4.  Right ventricle in acute and chronic pulmonary embolism (2013 Grover Conference series).

Authors:  Christian Gerges; Nika Skoro-Sajer; Irene M Lang
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

5.  Exercise-induced pulmonary arterial hypertension.

Authors:  James J Tolle; Aaron B Waxman; Teresa L Van Horn; Paul P Pappagianopoulos; David M Systrom
Journal:  Circulation       Date:  2008-11-03       Impact factor: 29.690

6.  Endotoxemic pulmonary hypertension is largely mediated by endothelin-induced venous constriction.

Authors:  Patrik Rossi; Björn Persson; Piet J M Boels; Anders Arner; Eddie Weitzberg; Anders Oldner
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

7.  Pulmonary vascular dysfunction secondary to pulmonary arterial hypertension: insights gained through retrograde perfusion.

Authors:  Chun Zhou; Edward S Crockett; Lynn Batten; Ivan F McMurtry; Troy Stevens
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-18       Impact factor: 5.464

Review 8.  The physiological basis of pulmonary arterial hypertension.

Authors:  Robert Naeije; Manuel J Richter; Lewis J Rubin
Journal:  Eur Respir J       Date:  2022-06-16       Impact factor: 33.795

9.  Pulmonary capillary pressure in pulmonary hypertension.

Authors:  Rogerio Souza; Marcelo Britto Passos Amato; Sergio Eduardo Demarzo; Daniel Deheinzelin; Carmen Silvia Valente Barbas; Guilherme Paula Pinto Schettino; Carlos Roberto Ribeiro Carvalho
Journal:  Crit Care       Date:  2005-02-11       Impact factor: 9.097

10.  Estimation of pulmonary capillary pressure: different methods for different pathophysiological processes?

Authors:  Silvia Nunes
Journal:  Crit Care       Date:  2005-02-17       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.